Wolverine Trading, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	SELL	$2.0 - $3.2 $27,056 - $43,289	-13,528 Reduced 50.14%	13,451 $27,000
Q1 2023 May 15, 2023	BUY	$1.43 - $3.3 $38,579 - $89,030	26,979 New	26,979 $67,000
Q4 2020 Feb 12, 2021	BUY	$3.99 - $17.73 $99,590 - $442,540	24,960 New	24,960 $116,000
Q1 2020 May 11, 2020	SELL	$4.01 - $8.88 $82,381 - $182,430	-20,544 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$3.62 - $4.29 $38,715 - $45,881	-10,695 Reduced 34.24%	20,544 $88,000
Q3 2019 Nov 14, 2019	SELL	$3.54 - $4.48 $59,256 - $74,990	-16,739 Reduced 34.89%	31,239 $121,000
Q2 2019 Aug 20, 2019	BUY	$3.59 - $4.3 $116,330 - $139,337	32,404 Added 208.06%	47,978 $190,000
Q1 2019 May 15, 2019	BUY	$3.37 - $4.34 $52,484 - $67,591	15,574 New	15,574 $68,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $89.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.